Shares of Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the ten ratings firms that are covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $1,311.1111.
A number of equities research analysts have weighed in on the stock. Jefferies Financial Group raised shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and cut their price target for the company from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a report on Monday, May 5th. Evercore ISI cut their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a report on Monday, August 4th. Barclays assumed coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target for the company. Finally, Citigroup upped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st.
View Our Latest Report on Mettler-Toledo International
Mettler-Toledo International Stock Performance
NYSE:MTD opened at $1,285.99 on Thursday. The company has a market capitalization of $26.49 billion, a price-to-earnings ratio of 32.57, a price-to-earnings-growth ratio of 3.85 and a beta of 1.34. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,521.01. The stock has a 50-day simple moving average of $1,235.26 and a 200 day simple moving average of $1,187.41.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. Mettler-Toledo International's revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the business posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities research analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.
Insider Buying and Selling at Mettler-Toledo International
In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares of the company's stock, valued at approximately $6,750,875. This represents a 5.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares in the company, valued at $123,012.16. This represents a 63.71% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 1,827 shares of company stock valued at $2,371,208. 1.94% of the stock is owned by insiders.
Hedge Funds Weigh In On Mettler-Toledo International
A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in Mettler-Toledo International by 0.5% in the 2nd quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier's stock worth $3,003,415,000 after purchasing an additional 13,342 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Mettler-Toledo International by 71.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier's stock worth $1,062,257,000 after purchasing an additional 376,419 shares in the last quarter. Alliancebernstein L.P. increased its stake in Mettler-Toledo International by 1.1% in the 2nd quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier's stock worth $842,802,000 after purchasing an additional 8,121 shares in the last quarter. Geode Capital Management LLC increased its stake in Mettler-Toledo International by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier's stock worth $681,489,000 after purchasing an additional 3,383 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in Mettler-Toledo International by 5.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock worth $568,032,000 after purchasing an additional 25,272 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.
About Mettler-Toledo International
(
Get Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report